Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleClinical Studies

Ursolic Acid Promotes the Sensitization of rhTRAIL-resistant Triple-negative Breast Cancer

JASMINE M. MANOUCHEHRI and MICHAEL KALAFATIS
Anticancer Research December 2018, 38 (12) 6789-6795; DOI: https://doi.org/10.21873/anticanres.13050
JASMINE M. MANOUCHEHRI
1Department of Chemistry, Science and Research Center, Cleveland State University, Cleveland, OH, U.S.A.
2Center for Gene Regulation in Health and Disease (GRHD), Cleveland State University, Cleveland, OH, U.S.A.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MICHAEL KALAFATIS
1Department of Chemistry, Science and Research Center, Cleveland State University, Cleveland, OH, U.S.A.
2Center for Gene Regulation in Health and Disease (GRHD), Cleveland State University, Cleveland, OH, U.S.A.
3Department of Molecular Cardiology, Lerner Research Institute, Cleveland Clinic Foundation Cleveland, OH, U.S.A.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: m.kalafatis{at}csuohio.edu
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 38 no. 12 6789-6795
DOI 
https://doi.org/10.21873/anticanres.13050
PMID 
30504391

Published By 
International Institute of Anticancer Research
Print ISSN 
0250-7005
Online ISSN 
1791-7530
History 
  • Received August 15, 2018
  • Revision received November 1, 2018
  • Accepted November 2, 2018
  • Published online November 30, 2018.

Copyright & Usage 
Copyright© 2018, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved

Author Information

  1. JASMINE M. MANOUCHEHRI1,2 and
  2. MICHAEL KALAFATIS1,2,3⇑
  1. 1Department of Chemistry, Science and Research Center, Cleveland State University, Cleveland, OH, U.S.A.
  2. 2Center for Gene Regulation in Health and Disease (GRHD), Cleveland State University, Cleveland, OH, U.S.A.
  3. 3Department of Molecular Cardiology, Lerner Research Institute, Cleveland Clinic Foundation Cleveland, OH, U.S.A.
  1. Correspondence to: Michael Kalafatis, Department of Chemistry, Cleveland State University, 2351 Euclid Avenue, Science and Research Center SR370, Cleveland, OH 44115, U.S.A. Tel: +1 2166872460, Fax: +1 2166879298, e-mail: m.kalafatis{at}csuohio.edu
View Full Text

Statistics from Altmetric.com

Cited By...

  • 12 Citations
  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

PreviousNext
Back to top

In this issue

Anticancer Research
Vol. 38, Issue 12
December 2018
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Ursolic Acid Promotes the Sensitization of rhTRAIL-resistant Triple-negative Breast Cancer
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
6 + 0 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Ursolic Acid Promotes the Sensitization of rhTRAIL-resistant Triple-negative Breast Cancer
JASMINE M. MANOUCHEHRI, MICHAEL KALAFATIS
Anticancer Research Dec 2018, 38 (12) 6789-6795; DOI: 10.21873/anticanres.13050

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Ursolic Acid Promotes the Sensitization of rhTRAIL-resistant Triple-negative Breast Cancer
JASMINE M. MANOUCHEHRI, MICHAEL KALAFATIS
Anticancer Research Dec 2018, 38 (12) 6789-6795; DOI: 10.21873/anticanres.13050
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgements
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • A Landscape of Immunogenomics Assessments for Endemic Burkitt Lymphoma: Relevance to Outcomes
  • Predictive Role of PSA Kinetics in Oncological Outcomes of Metastatic Castration-sensitive Prostate Cancer
  • Antiemetic Efficacy of Aprepitant in Cisplatin–Gemcitabine Therapy for Biliary Tract Cancer: A Multicenter Study
Show more Clinical Studies

Keywords

  • apoptosis
  • breast cancer
  • c-FLIPL
  • death receptors
  • ursolic acid
  • rhTRAIL
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire